Advanced pancreatic neuroendocrine tumor patient treated with everolimus – case report
Journal Title: OncoReview - Year 2012, Vol 2, Issue 3
Abstract
The increasing incidence of gastroenteropancreatic neuroendocrine tumors is caused not exclusively by increasing number of new cases, but also by improved diagnostics. Proper diagnosis and evaluation of tumor differentiation lead to disease prognosis and selection of optimal treatment. Presented clinical case of pancreatic neuroendocrine tumor patient treated with everolimus proves the efficacy of targeted therapy.
Authors and Affiliations
Bogumiła Czartoryska-Arłukowicz
Limfohistiocytoza hemofagocytowa (HLH) indukowana przez chłoniaka – opis przypadku
Limfohistiocytoza hemofagocytowa (HLH) to rzadki (zwłaszcza u dorosłych) zespół objawów, w którym hiperzapalenie powoduje gorączkę, hepatosplenomegalię, pancytopenię i bez leczenia prowadzi do zgonu. Wśród wyników badań...
Nowe możliwości leczenia uogólnionego raka piersi
Mimo udoskonalania metod badań przesiewowych, wczesnego wykrywania raka piersi i nowych terapii rokowanie w raku piersi pozostaje złe. Zaawansowany, uogólniony rak piersi jest chorobą przewlekłą, nieuleczalną. Podstawową...
Advanced or metastatic non-small-cell lung cancer treatment - new Polish goverment regulation
The article presents the non-small-cell lung cancer current treatment recommendations in consideration of Polish government regulation.
Severe aortic stenosis in a patient with breast cancer
We present a case of 68-year-old female with severe symptomatic aortic stenosis and locally advanced breast cancer disqualified from mastectomy due to heart failure and from aortic valve replacement due to malignant neop...
QT prolongation due to targeted anticancer therapy
A growing number of targeted anticancer agents has shown the unexpected ability to induce QT interval prolongation. In addition, standard chemotherapeutics and a variety of conditions such as electrolyte abnormalities, e...